Published in Respir Physiol Neurobiol on September 08, 2010
Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia. J Cell Physiol (2011) 1.54
The impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms. Diabetol Metab Syndr (2015) 1.00
Sympathetic and catecholaminergic alterations in sleep apnea with particular emphasis on children. Front Neurol (2012) 0.99
Obstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target? Front Neurol (2012) 0.97
Carotid body denervation prevents fasting hyperglycemia during chronic intermittent hypoxia. J Appl Physiol (1985) (2014) 0.94
Xanthine oxidase mediates hypoxia-inducible factor-2α degradation by intermittent hypoxia. PLoS One (2013) 0.93
Cardiorespiratory coupling: common rhythms in cardiac, sympathetic, and respiratory activities. Prog Brain Res (2014) 0.89
Nocturnal pulse rate and symptomatic response in patients with obstructive sleep apnoea treated with continuous positive airway pressure for one year. J Thorac Dis (2014) 0.88
Chemoreceptors, baroreceptors, and autonomic deregulation in children with obstructive sleep apnea. Respir Physiol Neurobiol (2012) 0.88
Sympathetic inhibition attenuates hypoxia induced insulin resistance in healthy adult humans. J Physiol (2012) 0.87
Chemoreflexes, sleep apnea, and sympathetic dysregulation. Curr Hypertens Rep (2014) 0.86
Increased cardio-respiratory coupling evoked by slow deep breathing can persist in normal humans. Respir Physiol Neurobiol (2014) 0.85
Carotid body, insulin, and metabolic diseases: unraveling the links. Front Physiol (2014) 0.84
Angiotensin II type 1a receptors in subfornical organ contribute towards chronic intermittent hypoxia-associated sustained increase in mean arterial pressure. Am J Physiol Heart Circ Physiol (2014) 0.82
Role of hypoxia and HIF2α in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features. Adv Pharmacol (2013) 0.80
Carotid chemoreceptor "resetting" revisited. Respir Physiol Neurobiol (2012) 0.80
Sleep, sleep-disordered breathing and lipid homeostasis: translational evidence from murine models and children. Clin Lipidol (2012) 0.79
Hypobaric intermittent hypoxia attenuates hypoxia-induced depressor response. PLoS One (2012) 0.79
Intermittent hypoxia in childhood: the harmful consequences versus potential benefits of therapeutic uses. Front Pediatr (2015) 0.79
Peripheral chemoreceptors and cardiorespiratory coupling: a link to sympatho-excitation. Exp Physiol (2015) 0.78
Cardiovascular Regulation in Obstructive Sleep Apnea. Drug Discov Today Dis Models (2011) 0.78
Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases. Antioxid Redox Signal (2013) 0.78
Angiotensin II Type 1 Receptors and Systemic Hemodynamic and Renal Responses to Stress and Altered Blood Volume in Conscious Rabbits. Front Physiol (2011) 0.77
Intermittent hypoxia and hypercapnia induce pulmonary artery atherosclerosis and ventricular dysfunction in low density lipoprotein receptor deficient mice. J Appl Physiol (1985) (2013) 0.76
Role of angiotensin-converting enzyme 1 within the median preoptic nucleus following chronic intermittent hypoxia. Am J Physiol Regul Integr Comp Physiol (2016) 0.75
Correlation of salivary alpha amylase level and adenotonsillar hypertrophy with sleep disordered breathing in pediatric subjects. J Clin Sleep Med (2014) 0.75
Commentary on CPAP vs. oxygen for treatment of OSA. J Clin Sleep Med (2014) 0.75
Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med (2000) 18.12
Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest (1995) 6.64
Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med (1993) 5.85
Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: implications for recurrent apneas. Proc Natl Acad Sci U S A (2003) 3.19
Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol (2006) 3.12
Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest (1993) 2.24
Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea. Eur Respir J (2000) 2.15
Effect of two paradigms of chronic intermittent hypoxia on carotid body sensory activity. J Appl Physiol (1985) (2003) 2.04
Invited review: Physiological consequences of intermittent hypoxia: systemic blood pressure. J Appl Physiol (1985) (2001) 2.00
Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress. J Physiol (2006) 1.86
Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation (1998) 1.76
Chronic intermittent hypoxia enhances cat chemosensory and ventilatory responses to hypoxia. J Physiol (2004) 1.73
Increased sympathetic outflow in juvenile rats submitted to chronic intermittent hypoxia correlates with enhanced expiratory activity. J Physiol (2008) 1.66
NADPH oxidase is required for the sensory plasticity of the carotid body by chronic intermittent hypoxia. J Neurosci (2009) 1.65
Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens (1999) 1.62
Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens Suppl (1988) 1.55
Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension (2001) 1.52
Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J Appl Physiol (1985) (1997) 1.50
Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J Appl Physiol (1985) (2001) 1.46
Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol (1985) (1995) 1.45
Combined hypoxia and hypercapnia evokes long-lasting sympathetic activation in humans. J Appl Physiol (1985) (1995) 1.44
Sympathetic muscle nerve activity during sleep in man. Brain (1991) 1.44
Chronic intermittent hypoxia augments chemoreflex control of sympathetic activity: role of the angiotensin II type 1 receptor. Respir Physiol Neurobiol (2010) 1.39
Chronic intermittent hypoxia increases sympathetic responsiveness to hypoxia and hypercapnia. J Appl Physiol (1985) (1999) 1.38
Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol (1985) (2002) 1.35
Role of hypoxemia in sleep apnea-induced sympathoexcitation. J Auton Nerv Syst (1996) 1.31
Enhanced sympathetic outflow and decreased baroreflex sensitivity are associated with intermittent hypoxia-induced systemic hypertension in conscious rats. J Appl Physiol (1985) (2006) 1.28
Systemic, cellular and molecular analysis of chemoreflex-mediated sympathoexcitation by chronic intermittent hypoxia. Exp Physiol (2006) 1.25
Acute intermittent hypoxia increases both phrenic and sympathetic nerve activities in the rat. Exp Physiol (2006) 1.24
Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens (2003) 1.24
Cardiovascular alterations by chronic intermittent hypoxia: importance of carotid body chemoreflexes. Clin Exp Pharmacol Physiol (2005) 1.24
Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest (1993) 1.24
Changes in muscle sympathetic nerve activity during sleep in humans. Neurology (1991) 1.21
The sympathetic nervous system and obstructive sleep apnea: implications for hypertension. J Hypertens (1997) 1.20
Hypoxia-mediated prolonged elevation of sympathetic nerve activity after periods of intermittent hypoxic apnea. J Appl Physiol (1985) (2003) 1.19
Neonatal intermittent hypoxia leads to long-lasting facilitation of acute hypoxia-evoked catecholamine secretion from rat chromaffin cells. J Neurophysiol (2009) 1.18
Contribution of endothelin-1 to the enhanced carotid body chemosensory responses induced by chronic intermittent hypoxia. Brain Res (2006) 1.17
Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep (1987) 1.16
Chronic-intermittent hypoxia: a model of sympathetic activation in the rat. Respir Physiol (2000) 1.16
Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy. Chest (2007) 1.15
NADPH oxidase-dependent regulation of T-type Ca2+ channels and ryanodine receptors mediate the augmented exocytosis of catecholamines from intermittent hypoxia-treated neonatal rat chromaffin cells. J Neurosci (2010) 1.14
Continuous positive airway pressure treatment improves baroreflex control of heart rate during sleep in severe obstructive sleep apnea syndrome. Am J Respir Crit Care Med (2002) 1.13
Increased secretory capacity of mouse adrenal chromaffin cells by chronic intermittent hypoxia: involvement of protein kinase C. J Physiol (2007) 1.08
Reactive oxygen species-dependent endothelin signaling is required for augmented hypoxic sensory response of the neonatal carotid body by intermittent hypoxia. Am J Physiol Regul Integr Comp Physiol (2008) 1.07
Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens (2007) 1.06
Long-term intermittent hypoxia increases sympathetic activity and chemosensitivity during acute hypoxia in humans. J Physiol (2006) 1.05
Neurocirculatory consequences of intermittent asphyxia in humans. J Appl Physiol (1985) (2000) 1.04
Selective impairment of central mediation of baroreflex in anesthetized young adult Fischer 344 rats after chronic intermittent hypoxia. Am J Physiol Heart Circ Physiol (2007) 1.04
Plasma levels of vascular endothelial markers in obstructive sleep apnea. Arch Med Res (2006) 1.01
A specific and potent pressor effect of hypoxia in patients with sleep apnea. Am Rev Respir Dis (1992) 0.98
Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia. Am J Physiol Heart Circ Physiol (2008) 0.97
Sleep apnea and hypertension. Chest (2000) 0.97
Obstructive sleep apnea: Plasma endothelin-1 precursor but not endothelin-1 levels are elevated and decline with nasal continuous positive airway pressure. Peptides (2005) 0.97
Sympathoexcitatory response to peripheral chemoreflex activation is enhanced in juvenile rats exposed to chronic intermittent hypoxia. Exp Physiol (2006) 0.96
Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients. Sleep (1993) 0.95
Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue. J Hypertens (1992) 0.95
Sympathetic response to chemostimulation in conscious rats exposed to chronic intermittent hypoxia. Respir Physiol Neurobiol (2009) 0.95
Effect of repetitive hypoxic apnoeas on baroreflex function in humans. J Physiol (2006) 0.93
Circulating endothelin-1 in obstructive sleep apnea. Endothelium (1997) 0.92
Daytime variability of baroreflex function in patients with obstructive sleep apnoea: implications for hypertension. Exp Physiol (2007) 0.88
Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: implications for recurrent apneas. Proc Natl Acad Sci U S A (2003) 3.19
Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol (2006) 3.12
H2S mediates O2 sensing in the carotid body. Proc Natl Acad Sci U S A (2010) 2.04
Endogenous H2S is required for hypoxic sensing by carotid body glomus cells. Am J Physiol Cell Physiol (2012) 1.79
ROS signaling in systemic and cellular responses to chronic intermittent hypoxia. Antioxid Redox Signal (2007) 1.71
Intermittent hypoxia degrades HIF-2alpha via calpains resulting in oxidative stress: implications for recurrent apnea-induced morbidities. Proc Natl Acad Sci U S A (2009) 1.63
Intermittent hypoxia activates peptidylglycine alpha-amidating monooxygenase in rat brain stem via reactive oxygen species-mediated proteolytic processing. J Appl Physiol (1985) (2008) 1.60
Role of oxidative stress in intermittent hypoxia-induced immediate early gene activation in rat PC12 cells. J Physiol (2004) 1.56
Role of oxidative stress-induced endothelin-converting enzyme activity in the alteration of carotid body function by chronic intermittent hypoxia. Exp Physiol (2013) 1.47
Intermittent hypoxia-induced endothelial barrier dysfunction requires ROS-dependent MAP kinase activation. Am J Physiol Cell Physiol (2014) 1.46
Transcriptional responses to intermittent hypoxia. Respir Physiol Neurobiol (2008) 1.36
5-HT evokes sensory long-term facilitation of rodent carotid body via activation of NADPH oxidase. J Physiol (2006) 1.33
NADPH oxidase 2 mediates intermittent hypoxia-induced mitochondrial complex I inhibition: relevance to blood pressure changes in rats. Antioxid Redox Signal (2010) 1.30
Hypoxia-inducible factor 2α (HIF-2α) heterozygous-null mice exhibit exaggerated carotid body sensitivity to hypoxia, breathing instability, and hypertension. Proc Natl Acad Sci U S A (2011) 1.28
Systemic, cellular and molecular analysis of chemoreflex-mediated sympathoexcitation by chronic intermittent hypoxia. Exp Physiol (2006) 1.25
Cardiovascular alterations by chronic intermittent hypoxia: importance of carotid body chemoreflexes. Clin Exp Pharmacol Physiol (2005) 1.24
Oxidative stress in the systemic and cellular responses to intermittent hypoxia. Biol Chem (2004) 1.23
Neonatal intermittent hypoxia leads to long-lasting facilitation of acute hypoxia-evoked catecholamine secretion from rat chromaffin cells. J Neurophysiol (2009) 1.18
Acetylcholine release from the carotid body by hypoxia: evidence for the involvement of autoinhibitory receptors. J Appl Physiol (1985) (2003) 1.14
NADPH oxidase-dependent regulation of T-type Ca2+ channels and ryanodine receptors mediate the augmented exocytosis of catecholamines from intermittent hypoxia-treated neonatal rat chromaffin cells. J Neurosci (2010) 1.14
Mutual antagonism between hypoxia-inducible factors 1α and 2α regulates oxygen sensing and cardio-respiratory homeostasis. Proc Natl Acad Sci U S A (2013) 1.14
Epigenetic regulation of hypoxic sensing disrupts cardiorespiratory homeostasis. Proc Natl Acad Sci U S A (2012) 1.13
Inherent variations in CO-H2S-mediated carotid body O2 sensing mediate hypertension and pulmonary edema. Proc Natl Acad Sci U S A (2014) 1.13
Central and peripheral factors contributing to obstructive sleep apneas. Respir Physiol Neurobiol (2013) 1.10
Facilitation of dopamine and acetylcholine release by intermittent hypoxia in PC12 cells: involvement of calcium and reactive oxygen species. J Appl Physiol (1985) (2003) 1.07
Reactive oxygen species-dependent endothelin signaling is required for augmented hypoxic sensory response of the neonatal carotid body by intermittent hypoxia. Am J Physiol Regul Integr Comp Physiol (2008) 1.07
Altered carotid body function by intermittent hypoxia in neonates and adults: relevance to recurrent apneas. Respir Physiol Neurobiol (2007) 1.06
Sympatho-adrenal activation by chronic intermittent hypoxia. J Appl Physiol (1985) (2012) 1.06
Pattern-specific sustained activation of tyrosine hydroxylase by intermittent hypoxia: role of reactive oxygen species-dependent downregulation of protein phosphatase 2A and upregulation of protein kinases. Antioxid Redox Signal (2009) 0.96
Enhanced neuropeptide Y synthesis during intermittent hypoxia in the rat adrenal medulla: role of reactive oxygen species-dependent alterations in precursor peptide processing. Antioxid Redox Signal (2011) 0.94
Angiotensin II evokes sensory long-term facilitation of the carotid body via NADPH oxidase. J Appl Physiol (1985) (2011) 0.94
Intermittent hypoxia-mediated plasticity of acute O2 sensing requires altered red-ox regulation by HIF-1 and HIF-2. Ann N Y Acad Sci (2009) 0.92
Intermittent hypoxia augments acute hypoxic sensing via HIF-mediated ROS. Respir Physiol Neurobiol (2010) 0.91
Neonatal intermittent hypoxia impairs neuronal nicotinic receptor expression and function in adrenal chromaffin cells. Am J Physiol Cell Physiol (2010) 0.86
NADPH oxidase-derived H(2)O(2) contributes to angiotensin II-induced aldosterone synthesis in human and rat adrenal cortical cells. Antioxid Redox Signal (2012) 0.85
Endothelin-1 mediates attenuated carotid baroreceptor activity by intermittent hypoxia. J Appl Physiol (1985) (2011) 0.85
Post-translational modification of glutamic acid decarboxylase 67 by intermittent hypoxia: evidence for the involvement of dopamine D1 receptor signaling. J Neurochem (2010) 0.84
Peripheral chemoreception and arterial pressure responses to intermittent hypoxia. Compr Physiol (2015) 0.84
Reactive oxygen species facilitate oxygen sensing. Novartis Found Symp (2006) 0.84
Detection of oxygen sensing during intermittent hypoxia. Methods Enzymol (2004) 0.81
Systemic and cellular responses to intermittent hypoxia: evidence for oxidative stress and mitochondrial dysfunction. Adv Exp Med Biol (2003) 0.81
Hydrogen peroxide differentially affects activity in the pre-Bötzinger complex and hippocampus. J Neurophysiol (2011) 0.81
Hypoxia-inducible factors and hypertension: lessons from sleep apnea syndrome. J Mol Med (Berl) (2015) 0.77
Differential regulation of tyrosine hydroxylase by continuous and intermittent hypoxia. Adv Exp Med Biol (2012) 0.76
Contrasting effects of intermittent and continuous hypoxia on low O(2) evoked catecholamine secretion from neonatal rat chromaffin cells. Adv Exp Med Biol (2009) 0.76
Hypoxia does not uniformly facilitate the release of multiple transmitters from the carotid body. Adv Exp Med Biol (2003) 0.75